Stay updated on AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.3 to v3.5.4, signaling a new release of the site software. This update reflects changes to the page framework or documentation without altering the study content or visible data on the page.
    Difference
    0.1%
    Check dated 2026-05-18T03:57:29.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    Updates the ClinicalTrials.gov page’s footer revision/version from v3.5.0 to v3.5.3, reflecting a platform release rather than study-specific information.
    Difference
    0.1%
    Check dated 2026-04-26T15:18:40.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    Revision indicator updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-21T16:25:05.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-07T05:50:25.000Z thumbnail image
  8. Check
    112 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.1 to v3.4.2. This is a minor UI/metadata change with no impact on study details.
    Difference
    0.1%
    Check dated 2026-02-13T17:26:55.000Z thumbnail image
  9. Check
    119 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.0 to v3.4.1. No changes to study content or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-02-06T11:27:12.000Z thumbnail image

Stay in the know with updates to AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial page.